150 related articles for article (PubMed ID: 38622523)
21. Hypoglycemic effect of astragaloside IV via modulating gut microbiota and regulating AMPK/SIRT1 and PI3K/AKT pathway.
Gong P; Xiao X; Wang S; Shi F; Liu N; Chen X; Yang W; Wang L; Chen F
J Ethnopharmacol; 2021 Dec; 281():114558. PubMed ID: 34438030
[TBL] [Abstract][Full Text] [Related]
22. Astragaloside IV suppresses inflammatory response via suppression of NF-κB, and MAPK signalling in human bronchial epithelial cells.
Hsieh HL; Liu SH; Chen YL; Huang CY; Wu SJ
Arch Physiol Biochem; 2022 Jun; 128(3):757-766. PubMed ID: 32057253
[TBL] [Abstract][Full Text] [Related]
23. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
24. Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF‑β1‑mediated PI3K and MAPK pathways.
Zhang L; Zhou J; Qin X; Huang H; Nie C
Oncol Rep; 2019 May; 41(5):2975-2986. PubMed ID: 30896841
[TBL] [Abstract][Full Text] [Related]
25. [Mechanism of Polypeptide Extract from Scorpion Venom Combined Rapamycin in Enhancing Autophagy of H22 Hepatoma Cells: an Experimental Study].
Zhao QQ; Zhang WD; Wu LC; Zhang LL; Wang ZP; Zhang YY; Wang ZX; Jia Q
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jul; 35(7):866-70. PubMed ID: 26380452
[TBL] [Abstract][Full Text] [Related]
26. The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy.
Li Z; Yang W; Yang Y; Wu J; Luo P; Liu Y
Drug Des Devel Ther; 2022; 16():647-664. PubMed ID: 35308255
[TBL] [Abstract][Full Text] [Related]
27. Ursolic acid restores sensitivity to gemcitabine through the RAGE/NF-κB/MDR1 axis in pancreatic cancer cells and in a mouse xenograft model.
Li ZY; Chen SY; Weng MH; Yen GC
J Food Drug Anal; 2021 Jun; 29(2):262-274. PubMed ID: 35696208
[TBL] [Abstract][Full Text] [Related]
28. Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4 + T cells and altering gut microbiota.
Weng S; Huang L; Cai B; He L; Wen S; Li J; Zhong Z; Zhang H; Huang C; Yang Y; Jiang Q; Liu F
Chin Med; 2023 Aug; 18(1):97. PubMed ID: 37542273
[TBL] [Abstract][Full Text] [Related]
29. [Inhibitive effect of polypeptide extract from scorpion venom on repopulation in H22 tumor cell during chemotherapy].
Wang Z; Zhang W; Jia Q; Wang Z; Zhang Y; Wang Y
Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(1):108-13. PubMed ID: 20349728
[TBL] [Abstract][Full Text] [Related]
30. Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.
Zhai Y; Zhou W; Yan X; Qiao Y; Guan L; Zhang Z; Liu H; Jiang J; Liu J; Peng L
Phytomedicine; 2022 Dec; 107():154444. PubMed ID: 36155217
[TBL] [Abstract][Full Text] [Related]
31. Chemosensitive effects of Astragaloside IV in osteosarcoma cells via induction of apoptosis and regulation of caspase-dependent Fas/FasL signaling.
Hu T; Fei Z; Wei N
Pharmacol Rep; 2017 Dec; 69(6):1159-1164. PubMed ID: 29128795
[TBL] [Abstract][Full Text] [Related]
32. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.
Chen H; Zhang F; Li R; Liu Y; Wang X; Zhang X; Xu C; Li Y; Guo Y; Yao Q
Biomed Pharmacother; 2020 Apr; 124():109829. PubMed ID: 31958765
[TBL] [Abstract][Full Text] [Related]
33. The effect of Astragaloside IV on ethanol-induced gastric mucosal injury in rats: Involvement of inflammation.
Qin S; Huang K; Fang Z; Yin J; Dai R
Int Immunopharmacol; 2017 Nov; 52():211-217. PubMed ID: 28942222
[TBL] [Abstract][Full Text] [Related]
34. Scorpion venom activates natural killer cells in hepatocellular carcinoma via the NKG2D-MICA pathway.
Chen H; Zhidan W; Xia R; Zhaoxia W; Qing J; Qiang G; Haipeng Y; Hengxiao W
Int Immunopharmacol; 2016 Jun; 35():307-314. PubMed ID: 27089390
[TBL] [Abstract][Full Text] [Related]
35. Astragaloside IV inhibits NF- κ B activation and inflammatory gene expression in LPS-treated mice.
Zhang WJ; Frei B
Mediators Inflamm; 2015; 2015():274314. PubMed ID: 25960613
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effects of tetramethylpyrazine and astragaloside IV on spinal cord injury via alteration of astrocyte A1/A2 polarization through the Sirt1-NF-κB pathway.
Rao Y; Li J; Qiao R; Luo J; Liu Y
Int Immunopharmacol; 2024 Apr; 131():111686. PubMed ID: 38461631
[TBL] [Abstract][Full Text] [Related]
37. Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-κB/NLRP3 inflammasome axis.
Song MT; Ruan J; Zhang RY; Deng J; Ma ZQ; Ma SP
Acta Pharmacol Sin; 2018 Oct; 39(10):1559-1570. PubMed ID: 29795356
[TBL] [Abstract][Full Text] [Related]
38. Ferulic acid combined with astragaloside IV protects against vascular endothelial dysfunction in diabetic rats.
Yin Y; Qi F; Song Z; Zhang B; Teng J
Biosci Trends; 2014 Aug; 8(4):217-26. PubMed ID: 25224628
[TBL] [Abstract][Full Text] [Related]
39. Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
Zhao XM; Zhang J; Liang YN; Niu YC
Dig Dis Sci; 2020 Oct; 65(10):2925-2936. PubMed ID: 31900718
[TBL] [Abstract][Full Text] [Related]
40. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
Wang X; Gao S; Song L; Liu M; Sun Z; Liu J
Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
